‘I don’t have the time’: Why the CDC won’t disclose new data about the new coronavirus
It’s not that there’s nothing to report.
This is not the end of the story.
The Centers for Disease Control and Prevention is planning to update its coronaviruses data set for the next two months, the agency said Thursday, the first time in more than a decade that the data will be made public.
The data, which will include the coronaviral strain in use for the time being, will be released “in the next couple of weeks,” according to a release from the agency.
But it was not immediately clear when the data would be released or whether the update would cover all the new data in the past three months.
The agency also said that its website will be down for a while.
It’s been nearly two months since the first case of the new virus was detected in the U.S. and is spreading rapidly across the country, with a majority of the infections coming from people living in the Midwest and West.
The new virus is known as Zaire-CoV-19.
The CDC is not releasing a timeline for when the new information will be available.
It did not release the full set of data that was previously public, which it shared with the public on Oct. 2, 2016.
But that information was not available for several months, as the agency worked to determine how to share the data.
CDC scientists and public health officials have been working on the new vaccine and have been collecting data for about two years.
At the time, the vaccine was still in development and no one knew what the risks of using the vaccine were.
That was because the vaccine didn’t work as well in clinical trials, and many studies of the vaccine in the United States had shown that it didn’t prevent the spread of the virus.
As of the time the CDC released the data, the new pandemic had already spread more than 9 million people, and more than 1,500 deaths.
The pandemic has affected not only the U and U.K., but also Europe, Japan, Australia, New Zealand, Canada, and other countries.
“I don.t. have the opportunity to do that right now,” said Dr. Scott G. Thompson, a senior virologist at the University of Alabama in Huntsville, who has been working with the CDC on the coronavetas vaccine.
“We are in the midst of a pandemic that is killing thousands of Americans, but we’re not yet prepared for the impact that we’re going to have with this new virus.”
Dr. Thompson and his colleagues were working to develop a vaccine that could prevent coronavaccine-associated pneumonia.
The team also was working on a vaccine for an outbreak of SARS-CoQ-19, a coronavillosis that caused hundreds of deaths in China in 2003 and 2008.
Both vaccines were in development.
The vaccine was approved in April and the coronava vaccine is currently undergoing clinical trials.
“It’s important that we are aware of the impact of the pandemic, and that we don’t wait to do something when we know we’re losing people,” Dr. G. Thomas Fauci, director of the CDC’s influenza pandemic and respiratory diseases branch, said at a press conference in May.
“The best way to deal with this problem is to prepare.”
The CDC also said it is planning a large-scale public education campaign to raise awareness about the pandemics.
But for now, the public can only wait to see if the data for the new vaccines will be publicly released.